Julie Krop
2019
In 2019, Julie Krop earned a total compensation of $1.3M as Chief Medical Officer and Executive Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $148,469 |
| Option Awards | $195,255 |
| Salary | $468,689 |
| Stock Awards | $446,850 |
| Other | $11,200 |
| Total | $1,320,463 |
Krop received $468.7K in salary, accounting for 35% of the total pay in 2019.
Krop also received $50K in bonus, $148.5K in non-equity incentive plan, $195.3K in option awards, $446.9K in stock awards and $11.2K in other compensation.
Rankings
In 2019, Julie Krop's compensation ranked 7,955th out of 13,971 executives tracked by ExecPay. In other words, Krop earned more than 43.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,955 out of 13,971 | 43rd |
Division Manufacturing | 3,133 out of 5,695 | 45th |
Major group Chemicals And Allied Products | 1,186 out of 2,194 | 46th |
Industry group Drugs | 1,012 out of 1,880 | 46th |
Industry Pharmaceutical Preparations | 752 out of 1,392 | 46th |
Pay ratio
| Julie Krop's Pay | $1,320,463 |
|---|---|
| Median Employee's Pay | $189,221 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Julie Krop was $1,320,463.
The annual total compensation of the median employee at AMAG Pharmaceuticals was $189,221.
The ratio of Julie Krop's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 29, 2020.
Krop's colleagues
We found four more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2019.